Summary
CURE Chart
CURE: Make an Adventurous Bet on an Undervalued Sector
The healthcare sector, the fifth-largest sector exposure in the S&P 500, was once a reliable destination for investors who wanted dependable performance without taking on significant risk. The group has lived up to its reputation for being less volatile than the broader market.
Top Performing Leveraged/Inverse ETFs: 07/27/2025
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
CURE: A Useful Speculative Tool But Not An Investing Hold
CURE is designed for daily 3x leveraged exposure to the healthcare sector, making it suitable for short-term speculation or hedging, not long-term investment. Daily resets and derivatives costs cause value decay over time, so holding CURE for months or years leads to underperformance versus the underlying index. CURE is effective for tactical trades or hedges on short-term healthcare sector moves, but not for buy-and-hold strategies.
VanEck Genomic Health Innovators ETF (CURE) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has VanEck Genomic Health Innovators ETF ever had a stock split?
VanEck Genomic Health Innovators ETF Profile
| XMIL Exchange | US Country |
Overview
This fund is designed for investors seeking aggressive investment exposure to the healthcare sector. By committing at least 80% of its net assets to financial instruments that offer 3X daily leveraged exposure to a specific index, the fund aims to amplify the returns of its underlying index on a day-to-day basis. The index in question is comprised of domestic companies operating within the healthcare sector. This includes a broad range of industries from pharmaceuticals and biotechnology to health care equipment, providers, and services. The fund's strategy is characterized by its non-diversified nature, focusing on maximizing the leveraged returns from this specific sector. It's crucial for potential investors to understand the inherent risks and rewards associated with leveraging, as it significantly magnifies both gains and losses depending on the daily index performance.
Products and Services
- 3X Daily Leveraged Exposure
This product is the cornerstone of the fund, aiming to triple the daily performance of its healthcare sector index. It's achieved through leveraging, a technique that uses financial instruments like futures and options to increase potential returns. Intended for experienced investors who are comfortable with high risk for the chance of high reward, this aggressive strategy highlights the fund's focus on capitalizing on short-term movements within the healthcare sector.
- Healthcare Sector Investments
The fund targets an array of industries within the healthcare sector, ensuring a focused yet comprehensive coverage. This includes investments in:
- Pharmaceuticals - Companies involved in the research, development, and marketing of medications.
- Health Care Equipment and Supplies - Firms that produce medical equipment, supplies, and devices for healthcare providers.
- Health Care Providers and Services - Entities that offer medical services directly to patients, ranging from hospital systems to specialized health services.
- Biotechnology - Companies focused on the technological application that uses biological systems or living organisms for the development of drugs, treatments, and therapies.
- Life Sciences Tools and Services - Organizations providing the necessary tools, services, and technologies for research and development in the life sciences field.
This diversified approach within the healthcare sector itself allows the fund to capitalize on various growth opportunities, from established pharmaceutical giants to emerging biotech innovators.
Contact Information
